These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26713639)
1. Retrospective data collection of psoriasis treatment with fumaric acid esters in children and adolescents in Germany (KIDS FUTURE study). Reich K; Hartl C; Gambichler T; Zschocke I J Dtsch Dermatol Ges; 2016 Jan; 14(1):50-8. PubMed ID: 26713639 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis--a retrospective study (FUTURE). Reich K; Thaci D; Mrowietz U; Kamps A; Neureither M; Luger T J Dtsch Dermatol Ges; 2009 Jul; 7(7):603-11. PubMed ID: 19459898 [TBL] [Abstract][Full Text] [Related]
3. Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre. Steinz K; Gerdes S; Domm S; Mrowietz U Dermatology; 2014; 229(3):199-204. PubMed ID: 25247273 [TBL] [Abstract][Full Text] [Related]
4. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study. Dickel H; Bruckner T; Altmeyer P J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS). Thaçi D; Weisenseel P; Philipp S; Rosenbach T; Rotterdam S; Augustin M; Neureither M; Reich K J Dtsch Dermatol Ges; 2013 May; 11(5):429-35. PubMed ID: 23433431 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands. Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate-to-severe plaque psoriasis (FAST). Weisenseel P; Reich K; Griemberg W; Merten K; Gröschel C; Gomez NN; Taipale K; Bräu B; Zschocke I J Dtsch Dermatol Ges; 2017 Feb; 15(2):180-186. PubMed ID: 28214304 [TBL] [Abstract][Full Text] [Related]
8. Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care. Mrowietz U; Sorbe C; Reich K; Von Kiedrowski R; Weckbecker J; Radtke MA; Rustenbach SJ; Augustin M Eur J Dermatol; 2020 Feb; 30(1):41-48. PubMed ID: 32250255 [TBL] [Abstract][Full Text] [Related]
9. Drug survival of fumaric acid esters for psoriasis: a retrospective study. Ismail N; Collins P; Rogers S; Kirby B; Lally A Br J Dermatol; 2014 Aug; 171(2):397-402. PubMed ID: 24471408 [TBL] [Abstract][Full Text] [Related]
10. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities. Balasubramaniam P; Stevenson O; Berth-Jones J Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371 [TBL] [Abstract][Full Text] [Related]
11. Regulated genes in psoriatic skin during treatment with fumaric acid esters. Onderdijk AJ; Balak DM; Baerveldt EM; Florencia EF; Kant M; Laman JD; van IJcken WF; Racz E; de Ridder D; Thio HB; Prens EP Br J Dermatol; 2014 Oct; 171(4):732-41. PubMed ID: 24852654 [TBL] [Abstract][Full Text] [Related]
12. Fumaric acid esters for psoriasis: a systematic review. Smith D Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164 [TBL] [Abstract][Full Text] [Related]